Jazz Pharmaceuticals plc Litigation Settlement Loss
Jazz Pharmaceuticals plc (JAZZ) reported Litigation Settlement Loss of $172.00 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LitigationSettlementLoss · last filed 2025-08-06
- 2025-06-30: Litigation Settlement Loss 6 month $172.00M.
| Period end | Litigation Settlement Loss 6 month |
|---|---|
| 2025-06-30 | $172.00M 10-Q · filed 2025-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |